• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Inkbit Raises $12 Million in Equity Round Led by Stratasys and DSM Venturing to Propel Production of Its Vision-Based, Artificial Intelligence Additive Manufacturing Platform

Share:

November 11, 2019

Inkbit, the company that built the first 3D printer driven by vision-based feedback control and artificial intelligence, announced today the closing of a $12M equity financing round led by Stratasys and DSM Venturing, the venture capital arm of Royal DSM, with additional participation from Ocado, 3M and Saint-Gobain. This new capital raise follows on the company’s first $2.8M round led by IMA, a leader in pharmaceutical processing equipment, closed in December of 2017. Inkbit is also funded by the Defense Advanced Research Projects Agency (DARPA), the National Science Foundation and MassVentures.

Proceeds will be used to industrialize Inkbit’s additive manufacturing system to fit the requirements of multi-material and volume manufacturing, expand the set of materials for medical, life sciences and robotics applications and install the first units for customers.

“We are excited to partner with such an extraordinary team of industry-leading players and impressed by their entrepreneurial spirit and commitment to innovation,” said Davide Marini, Inkbit cofounder and CEO. “The composition of this syndicate was chosen to maximize the speed of development and commercialization of our platform, with each investor bringing to us their unique expertise in equipment manufacturing, high-performance materials and applications in robotics, medical devices and life sciences tools. Our value proposition to customers is simple: we are adding a layer of machine vision and machine learning to material jetting, increasing its accuracy, reliability and enabling its use with production-grade materials.”

“As pioneers of jetting-based additive manufacturing solutions, we are excited to help Inkbit bring their technology to the factory floor. Vision-based feedback control and artificial intelligence will take additive manufacturing to a whole new level and will help to enable its widespread use for production,” said Ronen Lebi, Vice President of Corporate Development at Stratasys.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Materials always play a major role in industrializing breakthrough technologies and in additive manufacturing they become absolutely critical. We are delighted to have Inkbit in our investment portfolio and look forward to helping them develop the best materials for customers world-wide,” said Pieter Wolters, Managing Director of DSM Venturing.

2D material jetting is currently used across a range of industrial processes, such as ceramic and textile manufacturing. While its 3D counterpart is well proven in prototyping applications, limited material choice has restricted its use in production. The contactless material jetting process developed by Inkbit eliminates the need for planarization and enables printing of multi-material parts with production-grade materials.

Inkbit has begun working with customers, such as Johnson & Johnson, through an early access program to develop an initial set of applications. The company plans to release the first systems in 2021 to select customers. Inkbit machines will provide customers with volume production capabilities, higher accuracy and automated quality assurance for every printed part.

Joining Inkbit’s Board of Directors will be Guy Menchik, VP of R&D at Stratasys, Luda Kopeikina, Director of DSM Venturing, Paul Clarke, Ocado’s CTO and Magnus René, CEO at Ovzon and formerly CEO at Arcam.

Source: Venture Beat

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • North Carolina Taps Phreesia to Help with Social Determinants of HealthNorth Carolina Taps Phreesia to Help with Social Determinants of Health
  • HPS/PayMedix to Expand $25M for Healthcare Financing SolutionHPS/PayMedix to Expand $25M for Healthcare Financing Solution
  • Northwestern to Deploy FDA-Cleared Deploy AI-Guided Cardiac UltrasoundsNorthwestern to Deploy FDA-Cleared Deploy AI-Guided Cardiac Ultrasounds
  • BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and DevelopmentBioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
  • Life Science Cares Announces Impact Level Partnership with Kura OncologyLife Science Cares Announces Impact Level Partnership with Kura Oncology
  • Insights on the Microbial Contract Biomanufacturing Global Market to 2030 – Featuring AGC Biologics, Aldevron and BioVectra Among OthersInsights on the Microbial Contract Biomanufacturing Global Market to 2030 – Featuring AGC Biologics, Aldevron and BioVectra Among Others
  • FTC, Department of Justice Release New Draft Merger GuidelinesFTC, Department of Justice Release New Draft Merger Guidelines
  • Influenza B Infection Market in 2021 – Detailed Analysis ReportInfluenza B Infection Market in 2021 – Detailed Analysis Report

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications